AR109907A2 - Métodos para la producción de proteínas morfogenéticas óseas - Google Patents

Métodos para la producción de proteínas morfogenéticas óseas

Info

Publication number
AR109907A2
AR109907A2 ARP170102812A ARP170102812A AR109907A2 AR 109907 A2 AR109907 A2 AR 109907A2 AR P170102812 A ARP170102812 A AR P170102812A AR P170102812 A ARP170102812 A AR P170102812A AR 109907 A2 AR109907 A2 AR 109907A2
Authority
AR
Argentina
Prior art keywords
production
bmp
methods
concentration
present
Prior art date
Application number
ARP170102812A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40740265&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR109907(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR109907A2 publication Critical patent/AR109907A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan métodos y procesos para la producción de proteína recombinante. Los métodos son útiles para la producción de factores de crecimiento, en particular los de la superfamilia de TGF-b, que incluyen. proteínas morfogenéticas óseas (BMP), tales como BMP-2. Las células huésped adecuadas se cultivan en un medio en donde el hierro está presente en una concentración de al menos 2,25 mM y si el piridoxal está presente, constituye menos de 55% de la concentración molar de vitamina B6 del medio. Reivindicación 1: Un método de producción de BMP-2 que comprende las etapas de: i) cultivar una célula huésped adecuada que comprende una molécula de ADN que codifica una BMP-2 en un medio de cultivo que comprende hierro en una concentración de al menos 2,25 mM, un compuesto polianiónico y si está presente piridoxal, constituye menos de 55% de la concentración molar de vitamina B6 en el medio de cultivo; y ii) recuperar la proteína de interés, en donde la célula huésped se cultiva en un biorreactor que tiene una capacidad mayor de 3 L.
ARP170102812A 2008-04-17 2017-10-09 Métodos para la producción de proteínas morfogenéticas óseas AR109907A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4564308P 2008-04-17 2008-04-17

Publications (1)

Publication Number Publication Date
AR109907A2 true AR109907A2 (es) 2019-02-06

Family

ID=40740265

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090101366 AR071484A1 (es) 2008-04-17 2009-04-17 Metodos para la produccion aumentada de proteinas morfogeneticas oseas, tales como bmp-2.
ARP170102812A AR109907A2 (es) 2008-04-17 2017-10-09 Métodos para la producción de proteínas morfogenéticas óseas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP090101366 AR071484A1 (es) 2008-04-17 2009-04-17 Metodos para la produccion aumentada de proteinas morfogeneticas oseas, tales como bmp-2.

Country Status (19)

Country Link
US (1) US8039231B2 (es)
EP (1) EP2310523B1 (es)
JP (2) JP5739324B2 (es)
KR (1) KR101286895B1 (es)
CN (2) CN107090481A (es)
AR (2) AR071484A1 (es)
AU (1) AU2009236187B2 (es)
CA (1) CA2720980C (es)
CL (1) CL2009000912A1 (es)
DK (1) DK2310523T3 (es)
ES (1) ES2543061T3 (es)
HU (1) HUE027035T2 (es)
IL (1) IL208732A (es)
MX (1) MX2010011356A (es)
PL (1) PL2310523T3 (es)
PT (1) PT2310523E (es)
SI (1) SI2310523T1 (es)
WO (1) WO2009129379A1 (es)
ZA (1) ZA201007099B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2310523B1 (en) * 2008-04-17 2015-06-10 Wyeth LLC Methods for enhanced production of bone morphogenetic proteins
CA2793671A1 (en) * 2010-03-19 2011-09-22 Lifenet Health Bmp-2 peptides & methods of use
WO2011119829A1 (en) * 2010-03-24 2011-09-29 Lifenet Health Bmp-4 peptides & methods of use
US11078248B2 (en) 2010-03-19 2021-08-03 Lifenet Health BMP peptides and methods of use
US9926357B2 (en) * 2010-03-24 2018-03-27 Lifenet Health BMP-7 peptides and methods of use
WO2012006594A1 (en) 2010-07-08 2012-01-12 Baxter International Inc. Method of producing recombinant adamts13 in cell culture
US20130045471A1 (en) * 2011-02-25 2013-02-21 Bio-Rad Laboratories, Inc. Training system for investigations of bioengineered proteins
TW201247874A (en) * 2011-05-25 2012-12-01 United Biomedical Inc Method for producing the activity of bone activating protein
US20130281355A1 (en) * 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
EP3099324B1 (en) * 2014-01-30 2020-04-01 Coherus Biosciences, Inc. Perfusion media
WO2018194413A1 (en) * 2017-04-21 2018-10-25 Yuhan Corporation Method for producing dual function proteins and its derivatives
KR102056075B1 (ko) * 2018-06-05 2020-01-22 한국과학기술원 목적 단백질의 생산을 향상시키기 위한 동물세포 배양용 배지 조성물 및 이를 이용한 목적 단백질 생산 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5318898A (en) 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
US5830761A (en) 1995-06-07 1998-11-03 Genetics Institute, Inc. Medium and methods for culturing mammalian cho cells
US20030036629A1 (en) 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
WO2002077006A1 (en) * 2001-03-23 2002-10-03 Human Genome Sciences, Inc. Bone morphogenic protein polynucleotides, polypeptides, and antibodies
AU2002316230A1 (en) 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
ATE472597T2 (de) 2003-05-15 2010-07-15 Wyeth Llc Kontrollierte glukosezufuhr für tierzellkultur
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
TWI374935B (en) * 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
US7300773B2 (en) * 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
WO2006108455A1 (en) * 2004-11-02 2006-10-19 Ares Trading S.A. Serum-free cell culture medium for mammalian cells
EP2310523B1 (en) * 2008-04-17 2015-06-10 Wyeth LLC Methods for enhanced production of bone morphogenetic proteins

Also Published As

Publication number Publication date
IL208732A (en) 2014-07-31
AU2009236187A1 (en) 2009-10-22
PT2310523E (pt) 2015-09-07
IL208732A0 (en) 2010-12-30
CL2009000912A1 (es) 2009-10-09
JP2011518175A (ja) 2011-06-23
US20090317867A1 (en) 2009-12-24
SI2310523T1 (sl) 2015-10-30
JP5739324B2 (ja) 2015-06-24
CN107090481A (zh) 2017-08-25
US8039231B2 (en) 2011-10-18
AU2009236187B2 (en) 2012-08-02
MX2010011356A (es) 2010-11-09
WO2009129379A1 (en) 2009-10-22
HUE027035T2 (hu) 2016-08-29
CA2720980A1 (en) 2009-10-22
CA2720980C (en) 2014-02-25
JP2015109854A (ja) 2015-06-18
DK2310523T3 (en) 2015-07-20
EP2310523B1 (en) 2015-06-10
EP2310523A1 (en) 2011-04-20
ZA201007099B (en) 2011-06-29
ES2543061T3 (es) 2015-08-14
PL2310523T3 (pl) 2015-10-30
KR20110005874A (ko) 2011-01-19
AR071484A1 (es) 2010-06-23
CN102037132A (zh) 2011-04-27
KR101286895B1 (ko) 2013-07-16

Similar Documents

Publication Publication Date Title
AR109907A2 (es) Métodos para la producción de proteínas morfogenéticas óseas
EA200801074A1 (ru) Способы получения искусственных гибридных семян
PE20070796A1 (es) Metodo de produccion proteica utilizando compuestos anti-senescencia
CY1119923T1 (el) Μεθοδοι για αυξημενη παραγωγη πρωτεϊνων
PL2144929T3 (pl) Poprawa mian polipeptydu czynnika VIII w hodowlach komórkowych
BR122019022434B8 (pt) método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular
MX344970B (es) Medio de cultivo celular para la expresion de la proteina adamts.
WO2011075686A3 (en) Methods & compositions comprising heat shock proteins
BRPI0409895B8 (pt) método de cultura de células derivadas de células per.c6 capazes de crescer em suspensão para aumentar o rendimento de produto das referidas células
DE602006016735D1 (de) Verfahren zur proliferation von stammzellen
AR069253A1 (es) Plantas transgenicas que expresan el acido nucleico de ossik1 y moduladores para aumentar la tolerancia a estres
WO2011091350A3 (en) Methods & compositions for improving protein production
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
NZ595476A (en) Plant snf1-related protein kinase gene
WO2008024769A3 (en) Intensified perfusion production method
EA201170715A1 (ru) Вектор, содержащий множественные гомологичные нуклеотидные последовательности
GB2468624A (en) Cell culture system for pancreatic islands
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
MX2012007117A (es) Metodo para cultivar celulas adherentes.
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
MX2009007790A (es) Mejora del crecimiento celular.
ATE479741T1 (de) Zellkulturenmedium und verfahren zur kultivierung von stammzellen und vorläuferzellen
JP2013500003A5 (es)
EP2067857A4 (en) PROCESS FOR PRODUCING DIPEPTIDE
DE602007008863D1 (de) Verfahren zur herstellung differenzierter vogelzellen und an der aufrechterhaltung der pluripotenz beteiligter gene